ADAPTIMMUNE THERAPEUTICS PLC Operating Lease Right-of-Use Assets
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) had Operating Lease Right-of-Use Assets of $18.75 million as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-08-13
- 2025-06-30: Operating Lease, Right-of-Use Asset $18.75M.
- 2025-03-31: Operating Lease, Right-of-Use Asset $19.22M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $19.91M.
- 2024-09-30: Operating Lease, Right-of-Use Asset $20.49M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-06-30 | $18.75M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $19.22M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $19.91M 10-Q · filed 2025-08-13 |
| 2024-09-30 | $20.49M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $18.20M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $19.43M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $20.76M 10-K · filed 2025-03-24 |
| 2023-09-30 | $21.30M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $22.03M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $17.95M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $18.02M 10-K · filed 2024-03-06 |
| 2022-09-30 | $17.61M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $19.38M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $21.14M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $20.88M 10-K · filed 2023-03-06 |
| 2021-09-30 | $21.48M 10-Q · filed 2021-11-04 |
| 2021-08-13 | $4.29M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $17.77M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $18.33M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $18.88M 10-K · filed 2022-03-14 |
| 2020-09-30 | $18.77M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $18.89M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $19.50M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $20.79M 10-K · filed 2021-02-25 |
| 2019-09-30 | $20.56M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $21.51M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $24.46M 10-Q · filed 2019-05-06 |